Repare Therapeutics Inc.
0.20%
72,211
1808158
760273102
Nov 18, 2025
Nov 21, 2025, 08:24 PM
Reporting Persons (13)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Vantage I, L.P. | Partnership | 0.20% | 72,211 | 72,211 | 0 |
| Versant Vantage I GP, L.P. | Partnership | 0.20% | 72,211 | 0 | 72,211 |
| Versant Vantage I GP-GP, LLC | Other | 0.20% | 72,211 | 0 | 72,211 |
| Versant Ventures V, LLC | Other | 0.00% | 5,675 | 0 | 5,675 |
| Versant Venture Capital V (Canada) LP | Partnership | 0.00% | 6,814 | 6,814 | 0 |
| Versant Ventures V (Canada), L.P. | Partnership | 0.00% | 6,814 | 0 | 6,814 |
| Versant Venture Capital V, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| Versant Venture Capital VI, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| Versant Ventures VI GP-GP, LLC | Other | 0.00% | 0 | 0 | 0 |
| Versant Ventures V GP-GP (Canada), Inc. | CO | 0.00% | 6,814 | 0 | 6,814 |
| Versant Affiliates Fund V, L.P. | Partnership | 0.00% | 2,693 | 2,693 | 0 |
| Versant Ophthalmic Affiliates I, L.P. | Partnership | 0.00% | 2,982 | 2,982 | 0 |
Disclosure Items (3)
Common Shares
Repare Therapeutics Inc.
7171 Frederick Banting, Saint-Laurent, Quebec, Z4, H4S 1Z9
One Sansome Street, Suite 1650, San Francisco, CA 94104
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On November 19, 2025, VVC V sold 44,594 Common Shares at a price per share of $2.1605 for aggregate proceeds of approximately $96,345.34. On November 19, 2025, Versant VI sold 331,558 Common Shares at a price per share of $2.1605 for aggregate proceeds of approximately $716,331.06. On November 20, 2025, VVC V sold 237,107 Common Shares at a price per share of $2.1064 for aggregate proceeds of approximately $499,442.18. On November 20, 2025, Versant VI sold 1,762,893 Common Shares at a price per share of $2.1064 for aggregate proceeds of approximately $3,713,357.82. On November 20, 2025, Vantage LP sold 4,006 Common Shares at a price per share of $2.1275 for aggregate proceeds of approximately $8,522.77. On November 21, 2025, VAF V sold 5,782 Common Shares at a price per share of $2.1357 for aggregate proceeds of approximately $12,348.53. On November 21, 2025, VOA sold 6,399 Common Shares at a price per share of $2.1357 for aggregate proceeds of approximately $13,666.25. On November 21, 2025, VVC CAN sold 14,624 Common Shares at a price per share of $2.1357 for aggregate proceeds of approximately $31,232.26. On November 21, 2025, Vantage LP sold 154,994 Common Shares at a price per share of $2.1357 for aggregate proceeds of approximately $331,018.36.
November 20, 2025